Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

Black women with CCCA are more likely to have uterine fibroids.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Some gonadal hormone drugs can block filovirus entry into cells.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Clonally expanded CD8+ T cells cause alopecia areata.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

Ca²⁺-mediated protein citrullination controls cell growth in the CNS and may help treat brain tumors.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

A girl with symptoms like an autoimmune disorder actually had HIV and a fungal infection, which was hard to diagnose and treat, leading to her death.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

The treatment was not recommended due to limited effectiveness and significant side effects.